within Pharmacolibrary.Drugs.ATC.J;

model J01DC09
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 2.6666666666666667e-05,
    adminDuration  = 600,
    adminMass      = 1000 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0002,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>J01DC09</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Cefmetazole is a second-generation cephamycin antibiotic used for the treatment of infections caused by susceptible Gram-positive and Gram-negative bacteria. It is used primarily in Japan and some Asian countries for respiratory, urinary, and intra-abdominal infections, but is not widely approved in the US or EU.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult volunteers after single intravenous administration.</p><h4>References</h4><ol><li><p>Schentag, JJ (1991). Cefmetazole sodium: pharmacology, pharmacokinetics, and clinical trials. <i>Pharmacotherapy</i> 11(1) 2–19. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2020609/&quot;>https://pubmed.ncbi.nlm.nih.gov/2020609</a></p></li><li><p>Kaiki, Y, Ohge, H, Ikawa, K, Uegami, S, Watadani, Y, Shigemoto, N, Hirano, T, Yoshimura, K, Kitagawa, H, Morikawa, N, &amp; Takahashi, S (2023). Pharmacokinetics of cefmetazole in plasma, peritoneal fluid, peritoneum, and subcutaneous adipose tissue of patients scheduled for lower gastrointestinal surgery: Dosing considerations based on site-specific pharmacodynamic target attainment. <i>Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy</i> 29(3) 309–315. DOI:<a href=&quot;https://doi.org/10.1016/j.jiac.2022.12.005&quot;>10.1016/j.jiac.2022.12.005</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36549644/&quot;>https://pubmed.ncbi.nlm.nih.gov/36549644</a></p></li><li><p>Tan, JS, Salstrom, SJ, Signs, SA, Hoffman, HE, &amp; File, TM (1989). Pharmacokinetics of intravenous cefmetazole with emphasis on comparison between predicted theoretical levels in tissue and actual skin window fluid levels. <i>Antimicrobial agents and chemotherapy</i> 33(6) 924–927. DOI:<a href=&quot;https://doi.org/10.1128/AAC.33.6.924&quot;>10.1128/AAC.33.6.924</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2764542/&quot;>https://pubmed.ncbi.nlm.nih.gov/2764542</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end J01DC09;
